Hal Barron
Direktor/Vorstandsmitglied bei
GSK PLC
Vermögen: 15 Mio $ am Heute
Profil
Hal V. Barron bekleidet die Position des Executive Director & Chief Scientific Officer bei GlaxoSmithKline Plc. Dr. Barron ist außerdem Mitglied des Vorstands von GRAIL, Inc. und Kardiologe am UCSF Medical Center sowie außerordentlicher Professor an der University of California, San Francisco. Dr. Barron war zuvor Director & Senior Vice President-Development bei Arte Therapeutics, Inc, Chief Medical Officer & Executive Vice President bei Roche & Genentech, Inc, President bei Tesaro, Inc, Chief Medical Officer & EVP-Global Development bei Genentech, Inc, Chief Medical Officer & Executive Vice President bei F. Hoffmann-La Roche Ltd, Chief Medical Officer & Executive Vice President bei Roche Pharmaceuticals, Inc. und President-Research & Development bei Calico LLC. Er erhielt einen Doktortitel von der Yale University und einen Bachelor-Abschluss von der Washington University in St. Louis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GSK PLC 0,01 % | 15.05.2026 | 602.274 ( 0,01 % ) | 15 Mio $ | 31.05.2026 |
-.--% | 05.06.2026 | 255.833 ( -.--% ) | - $ | Heute |
Aktuelle Nachrichten zu Hal Barron
Aktive Positionen von Hal Barron
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Direktor/Vorstandsmitglied | 01.01.2018 |
Altos Labs, Inc.
 Altos Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on restoring cell health and rejuvenation resilience | Vorstandsvorsitzender | 01.08.2022 |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
UCSF Medical Center
 UCSF Medical Center Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Hal Barron
| Unternehmen | Position | Ende |
|---|---|---|
| JUNO THERAPEUTICS INC | Direktor/Vorstandsmitglied | 06.03.2018 |
Calico LLC
 Calico LLC BiotechnologyHealth Technology Operates as a research and technology company that develops therapies for age diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2017 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2013 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2013 |
| ALEXZA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 21.05.2013 |
Ausbildung von Hal Barron
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Arête Therapeutics, Inc.
 Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops and commercializes molecule drugs to treat cardiovascular diseases | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
UCSF Medical Center
UCSF Medical Center Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Calico LLC
Calico LLC BiotechnologyHealth Technology Operates as a research and technology company that develops therapies for age diseases | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Altos Labs, Inc.
Altos Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on restoring cell health and rejuvenation resilience | Health Technology |
